Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.

Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects.

Vila-Córcoles A, Ochoa-Gondar O, Llor C, Hospital I, Rodríguez T, Gómez A.

Eur Respir J. 2005 Dec;26(6):1086-91.

2.

Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study.

Vila-Córcoles A, Ochoa-Gondar O, Hospital I, Ansa X, Vilanova A, Rodríguez T, Llor C; EVAN Study Group.

Clin Infect Dis. 2006 Oct 1;43(7):860-8. Epub 2006 Aug 21.

PMID:
16941367
3.

Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up.

Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Gutierrez-Perez A, Vila-Rovira A, Gomez F, Raga X, de Diego C, Satue E, Salsench E; EPIVAC Study Group.

BMC Public Health. 2012 Mar 22;12:222. doi: 10.1186/1471-2458-12-222.

4.

Effectiveness of pneumococcal polysaccharide vaccine in older adults.

Jackson LA, Neuzil KM, Yu O, Benson P, Barlow WE, Adams AL, Hanson CA, Mahoney LD, Shay DK, Thompson WW; Vaccine Safety Datalink.

N Engl J Med. 2003 May 1;348(18):1747-55.

5.

Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study.

Ochoa-Gondar O, Vila-Corcoles A, Rodriguez-Blanco T, Gomez-Bertomeu F, Figuerola-Massana E, Raga-Luria X, Hospital-Guardiola I.

Clin Infect Dis. 2014 Apr;58(7):909-17. doi: 10.1093/cid/ciu002. Epub 2014 Feb 13.

PMID:
24532544
6.

Effectiveness of pneumococcal vaccination in older adults with chronic respiratory diseases: results of the EVAN-65 study.

Ochoa-Gondar O, Vila-Corcoles A, Ansa X, Rodriguez-Blanco T, Salsench E, de Diego C, Raga X, Gomez F, Valdivieso E, Fuentes C, Palacios L; EVAN Study Group.

Vaccine. 2008 Apr 7;26(16):1955-62. doi: 10.1016/j.vaccine.2008.02.021. Epub 2008 Feb 27.

PMID:
18343541
7.

Impact of the pneumococcal vaccine on long-term morbidity and mortality of adults at high risk for pneumonia.

Johnstone J, Eurich DT, Minhas JK, Marrie TJ, Majumdar SR.

Clin Infect Dis. 2010 Jul 1;51(1):15-22. doi: 10.1086/653114.

PMID:
20504233
8.

Rationale and design of the CAPAMIS study: effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke.

Vila-Corcoles A, Hospital-Guardiola I, Ochoa-Gondar O, de Diego C, Salsench E, Raga X, Fuentes-Bellido CM.

BMC Public Health. 2010 Jan 19;10:25. doi: 10.1186/1471-2458-10-25.

9.

Pneumococcal polysaccharide vaccine may not prevent hospitalization for pneumonia in elderly individuals.

Skull SA, Andrews RM, Byrnes GB, Kelly HA, Nolan TM, Brown GV, Campbell DA.

Clin Infect Dis. 2007 Feb 15;44(4):617; author reply 617-8. No abstract available.

PMID:
17260423
10.

Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: a matched case-control study.

Vila-Corcoles A, Salsench E, Rodriguez-Blanco T, Ochoa-Gondar O, de Diego C, Valdivieso A, Hospital I, Gomez-Bertomeu F, Raga X.

Vaccine. 2009 Mar 4;27(10):1504-10. doi: 10.1016/j.vaccine.2009.01.013. Epub 2009 Jan 24.

PMID:
19171174
11.

Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.

Baldo V, Cocchio S, Gallo T, Furlan P, Romor P, Bertoncello C, Buja A, Baldovin T.

PLoS One. 2016 Nov 15;11(11):e0166637. doi: 10.1371/journal.pone.0166637. eCollection 2016.

12.

Additive preventive effect of influenza and pneumococcal vaccines in elderly persons.

Christenson B, Hedlund J, Lundbergh P, Ortqvist A.

Eur Respir J. 2004 Mar;23(3):363-8.

13.

Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in patients with chronic pulmonary diseases: a matched case-control study.

Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Gutierrez-Perez A, Vila-Rovira A; EPIVAC Study Group.

Hum Vaccin Immunother. 2012 May;8(5):639-44. doi: 10.4161/hv.19466. Epub 2012 May 1.

PMID:
22634442
14.

Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group.

Ortqvist A, Hedlund J, Burman LA, Elbel E, Höfer M, Leinonen M, Lindblad I, Sundelöf B, Kalin M.

Lancet. 1998 Feb 7;351(9100):399-403.

PMID:
9482293
15.

Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly.

Domínguez A, Izquierdo C, Salleras L, Ruiz L, Sousa D, Bayas JM, Nebot M, Varona W, Celorrio JM, Carratalà J; Working Group for the Study of Prevention of CAP in the Elderly.

Eur Respir J. 2010 Sep;36(3):608-14. doi: 10.1183/09031936.00171309. Epub 2010 Jan 14.

16.

Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity.

Christenson B, Pauksen K, Sylvan SP.

Virol J. 2008 Apr 28;5:52. doi: 10.1186/1743-422X-5-52.

17.

Clinical effectiveness of pneumococcal polysaccharide vaccine in men: California Men's Health Study.

Hechter RC, Chao C, Jacobsen SJ, Slezak JM, Quinn VP, Van Den Eeden SK, Tseng HF.

Vaccine. 2012 Aug 17;30(38):5625-30. doi: 10.1016/j.vaccine.2012.06.085. Epub 2012 Jul 10.

PMID:
22789510
18.

Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up.

Vila-Córcoles A, Ochoa-Gondar O, Ester F, Sarrá N, Ansa X, Saún N; EVAN Study Group.

BMC Public Health. 2006 Sep 18;6:231.

19.

Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia.

Mykietiuk A, Carratalà J, Domínguez A, Manzur A, Fernández-Sabé N, Dorca J, Tubau F, Manresa F, Gudiol F.

Eur J Clin Microbiol Infect Dis. 2006 Jul;25(7):457-62.

PMID:
16773389
20.

Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan.

Kawakami K, Ohkusa Y, Kuroki R, Tanaka T, Koyama K, Harada Y, Iwanaga K, Yamaryo T, Oishi K.

Vaccine. 2010 Oct 8;28(43):7063-9. doi: 10.1016/j.vaccine.2010.08.010. Epub 2010 Aug 17.

PMID:
20723631

Supplemental Content

Support Center